Preview

Messenger of ANESTHESIOLOGY AND RESUSCITATION

Advanced search

Variants for dosing of rocuronium taken into obesity during general anesthesia in gynecological laparoscopic surgery

https://doi.org/10.24884/2078-5658-2024-21-5-14-19

Abstract

The objective was to identify the optimal method of dosing the muscle relaxant rocuronium during gynecological laparoscopic surgery in obese patients.

Materials and methods. The study included 36 women with obesity II–III degree, which performed elective gynecological laparoscopic surgery. They were divided into 3 groups. In group 1, rocuronium were dosed at the rate of 0.6 mg/kg of ideal body weight calculated by the Lorentz formula. In group 2, rocuronium were dosed at the rate of 0.6 mg/kg of actual body weight. In group 3, rocuronium were dosed at the rate of 22.5 mg/m2 of body surface area. The comparison group (group 0) included 20 patients with body mass index equal to 18.5–25 kg/m2.

Results. The shortest time for the onset of deep neuromuscular block was noted in groups 2 and 3, and the longest, comparable to the indicator in group 0, was in group 1 (p < 0.05). The time from rocuronium administration to the onset of restoration of neuromuscular conduction was the shortest in group 1: 22 [20; 25] minutes, and the longest in group 2: 40 [35; 45] min. There was no statistically significant difference in the dosing of rocuronium in obese patients at body surface area in group 3 compared with dosing for actual weight in group 0: 27 [22; 29] and 27 [25; 33] min, respectively. The recovery time of neuromuscular conduction from TOF = 1 to TOF = 25% was the shortest in group 1 (23 [18; 24] min) and was significantly different from the value in groups 2 and 3, as well as in patients of group 0. In groups 0, 2, 3, values of this indicator were identical. The recovery index did not differ significantly in all four groups.

Conclusion. Dosing rocuronium in obese patients based on body surface area has an advantage for comparison over dosing based on both actual and ideal body weight, resulting in greater predictability of neuromuscular block dynamics.

About the Authors

E. V. Polovnikov
Medical Center «Avicenna», MD Medical Group
Russian Federation

Polovnikov Evgenii V. - Anesthesiologist and Intensivist of the Department of Anesthesiology and Intensive Care

17, Kommunisticheksaya str., Novosibirsk, 630099



N. L. Elizar’eva
Novosibirsk State Medical University
Russian Federation

Elizar’eva Natalia L. - Dr. of Sci. (Med.), Professor of the Department of Anesthesiology and Intensive Care

52, Krasny pr., Novosibirsk, 630091



A. N. Shmakov
Novosibirsk State Medical University
Russian Federation

Shmakov Alexey N. - Dr. of Sci. (Med.), Professor of the Department of Anesthesiology and Intensive Care of the Faculty of Medicine

52, Krasny pr., Novosibirsk, 630091



V. N. Kokhno
Novosibirsk State Medical University
Russian Federation

Kokhno Vladimir N. - Dr. of Sci. (Med.), Professor, Head of the Department of Anesthesiology and Intensive Care of the Faculty of Medicine

52, Krasny pr., Novosibirsk, 630091



References

1. Gurin M. N., Golovach V. M., Berlev I. V., Glushchenko V. A., Rosengard S. A. Artificial lung ventilation in patients with morbid obesity during laparoscopic operations in the Trendelenburg position (literature review). Messenger of Anesthesiology and Resuscitation, 2023, vol. 20, no. 2, pp. 85‒90. (In Russ.) DOI: 10.24884/2078-5658-2022-20-2-85-90.

2. Shmakov A. N., Elizar’eva N. L., Kolosov A. N., Kokhno V. N., Samoylova L. B. The comparison of principles of rocuronium dosing in patients with hight body-weight index. Messenger of Anesthesiology and Resuscitation, 2015, vol. 12, no. 4, pp. 15‒20. (In Russ.) DOI: 10.21292/2078-5658-2015-12-4-15-20.

3. Adams J. P., Murphy P. G. Obesity in anaesthesia and intensive care. BJA: British Journal of Anaesthesia, 2000, vol. 85, Is.1, pp. 91‒108. DOI: 10.1093/bja/85.1.91.

4. An G., Qiu Y., Zhou Z. et al. Effects of a single dose of rocuronium in patients with different body fat percentages: A randomised controlled trial. Clin Exp Pharmacol Physiol, 2024, vol. 51, no. 3, e13836. DOI: 10.1111/1440-1681.

5. Brull S.J., Fulesdi B. Residual neuromuscular block in vulnerable patients: Obesity, obstructive sleep apnea and postoperative pulmonary complications. Rev Esp Anestesiol Reanim, 2019, vol. 66, no. 5, pp. 237‒240. DOI: 10.1016/j.redar.2019.03.005.

6. Farhan H., Moreno-Duarte I., McLean D. et al. Residual paralysis: does it influence outcome after ambulatory surgery? Curr Anesthesiol Rep, 2014, vol. 4, no. 4, pp. 290‒302. DOI: 10.1007/s40140-014-0073-6.

7. Godwin N. C., Rodriguez L., Banks S. et al. The effect of patient weight and provider training and experience on dosing of rocuronium. Anesthesiol Res Pract, 2016, 3136895. DOI: 10.1155/2016/3136895.

8. Leykin Y., Pellis T., Lucca M. et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg, 2004, vol. 99, no. 4, pp. 1086‒1089. DOI: 10.1213/01.ANE.0000120081.99080.C2.

9. Meyhoff C. S., Lund J., Jenstrup M. T. et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg, 2009, vol. 109, no. 3, pp. 787‒792. DOI: 10.1213/ane.0b013e3181b0826a.

10. Tsai C. C., Chung H. S., Chen P. L. et al. Postoperative residual curarization: clinical observation in the post-anesthesia care unit. Chang Gung Med J, 2008, vol. 31, no. 4, pp. 364‒368.


Review

For citations:


Polovnikov E.V., Elizar’eva N.L., Shmakov A.N., Kokhno V.N. Variants for dosing of rocuronium taken into obesity during general anesthesia in gynecological laparoscopic surgery. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2024;21(5):14-19. (In Russ.) https://doi.org/10.24884/2078-5658-2024-21-5-14-19



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5658 (Print)
ISSN 2541-8653 (Online)